Chapter 25 : Management of Point-of-Care Testing

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Management of Point-of-Care Testing, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817282/9781555817275_Chap25-1.gif /docserver/preview/fulltext/10.1128/9781555817282/9781555817275_Chap25-2.gif


Point-of-care testing (POCT) presents some of the most controversial and difficult laboratory management challenges. This chapter identifies how management of POCT differs from other types of laboratory testing. It describes cost factors in POCT and approaches for analysis of the costs of testing. One of the key initial steps in the management of POCT is the development of institutional goals. In developing the management structure for POCT, there are political issues that central administration and departmental leaders need to sort out. These include issues what department and who will direct testing, institutional priorities for POCT, and how costs and revenues will be assigned. The chapter explains how to operate a POCT program and to ensure the quality of testing. An important part of deciding whether a point-of-care test should be adopted is assessing its potential clinical impact. The chapter explains the challenges of implementing POCT in developing countries and the clinical benefit of POCT. One of the greatest challenges and a key to making POCT work is training and assurance of the competency of staff. The challenges of conducting quality POCT in developed countries with established hospital infrastructures are magnified when performed in the context of a developing country or rural setting. The chapter discusses how technological advances are driving change in the scope of POCT. Ongoing advances in the microfabrication of devices and in nanotechnology provide the promise of substantial future technological change and further reduction in the size of POCT devices.

Citation: Hortin G, Doern C. 2014. Management of Point-of-Care Testing, p 471-487. In Garcia L (ed), Clinical Laboratory Management, Second Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817282.ch25

Key Concept Ranking

Blood Glucose
Streptococcus pyogenes
Antiretroviral Therapy
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


1. Aghokeng, A. F.,, L. Ewane,, B. Awazi,, A. Nanfack,, E. Delaporte,, M. Peeters,, and L. Zekeng. 2004. Evaluation of four simple/rapid assays and two fourth-generation ELISAs for the identification of HIV infection on a serum panel representing the HIV-1 group M genetic diversity in Cameroon. J. Acquir. Immune Defic. Syndr. 37:16321640. [PubMed]
2. Alemnji, G.,, J. N. Nkengasong,, and B. S. Parekh. 2011. HIV testing in developing countries: what is required? Indian J. Med. Res. 134:779786. [PubMed][CrossRef]
3. Alves-Dunkerson, J. A.,, P. E. Hilsenrath,, G. A. Cress,, and J. A. Widness. 2002. Cost analysis of a neonatal point-of-care monitor. Am. J. Clin. Pathol. 117:809818. [PubMed][CrossRef]
4. Asimos, A. W.,, M. A. Gibbs,, J. A. Marx,, D. G. Jacobs,, R. J. Erwin,, H. J. Norton,, and M. Thomason. 2000. Value of point-of-care blood testing in emergent trauma management. J. Trauma 48:11011108. [PubMed]
5. Boone, D. J.,, J. W. Hay,, J. Aguanno,, T. Getzen,, and G. Hortin. 2002. Are the correct economic factors influencing point-of-care testing? Point of Care 1:212221.
6. Chmielewski, S. A. 1995. Advances and strategies for glucose monitoring. Am. J. Clin. Pathol. 104:S59S71. [PubMed]
7.College of American Pathologists. 2003. Point-of-care testing checklist. Laboratory Accreditation Program. College of American Pathologists, Northfield, IL.
8. De Cresce, R. P.,, D. L. Phillips,, and P. J. Howanitz. 1995. Financial justification of alternate site testing. Arch. Pathol. Lab. Med. 119:898901. [PubMed]
9. Despotis, G. J.,, J. E. Grishaber,, and L. T. Goodnough. 1994. The effect of an intraoperative treatment algorithm on physicians’ transfusion practice in cardiac surgery. Transfusion 34:290296. [PubMed]
10. Dessie, A.,, B. Abera,, F. Walle,, D. Wolday,, and W. Tamene. 2008. Evaluation of Determine HIV-1/2 rapid diagnostic test by 4th generation ELISA using blood donors’ serum at Felege Hiwot Referral Hospital, northwest Ethiopia. Ethiop. Med. J. 46:15. [PubMed]
10a. Dunka, L. J. 2006. Point-of-Care Connectivity. Approved Standard, CLSI publication POCT1A2. Clinical Laboratory Standards Institute, Wayne, PA.
11. Ehrmeyer, S. 2003. Using a creatinine ratio in urinalysis to improve the reliability of protein and albumin results. MLO Med. Lab. Obs. 35:2630. [PubMed]
12. Ehrmeyer, S. S.,, and R. H. Laessig. 2001. Electronic “quality control” (EQC): is it just for unit use devices? Clin. Chim. Acta 307:9599. [PubMed]
13. Ehrmeyer, S. S.,, and R. H. Laessig. 1995. Regulatory requirements (CLIA ’88, JCAHO, CAP) for decentralized testing. Am. J. Clin. Pathol. 104:S40S49. [PubMed]
14. Faal, M.,, N. Naidoo,, D. K. Glencross,, W. D. Venter,, and R. Osih. 2011. Providing immediate CD4 count results at HIV testing improves ART initiation. J. Acquir. Immune Defic. Syndr. 58:e54e59. [PubMed][CrossRef]
15. Felder, R. A.,, J. Savory,, K. S. Margrey,, J. W. Holman,, and J. C. Boyd. 1995. Development of a robotic near patient testing laboratory. Arch Pathol. Lab. Med. 119:9489451. [PubMed]
16. Fineberg, S. E.,, R. M. Bergenstal,, R. M. Bernstein,, L. M. Laffel,, and S. L. Schwartz. 2001. Use of an automated device for alternative site blood glucose monitoring. Diabetes Care 24:12171220. [PubMed]
17. Fitzgerald, P.,, S. W. Goodacre,, E. Cross,, and S. Dixon. 2011. Cost-effectiveness of point-of-care biomarker assessment for suspected myocardial infarction: the randomized assessment of treatment using panel assay of cardiac markers (RATPAC) trial. Acad. Emerg. Med. 18:488495. [PubMed][CrossRef]
18. George, S.,, and R. A. Braithwaite. 2002. Use of on-site testing for drugs of abuse. Clin. Chem. 48:16391646. [PubMed]
19. Grieve, R.,, R. Beech,, J. Vincent,, and J. Mazurkiewicz. 1999. Near patient testing in diabetes clinics: appraising the costs and outcomes. Health Technol. Assess. 3:174. [PubMed]
20. Gruszecki, A. C.,, G. Hortin,, J. Lam,, D. Kahler,, D. Smith,, J. Vines,, L. Lancaster,, T. M. Daly,, C. A. Robinson,, and R. W. Hardy. 2003. Utilization, reliability, and clinical impact of point-of-care testing during critical care transport: six years of experience. Clin. Chem. 49:10171019. [PubMed]
21. Hortin, G. 1998. Handbook of Bedside Glucose Testing. AACC Press, Washington, DC.
22. Hortin, G. L. 1997. Managing the forgotten bedside test—occult blood testing. Adv. Admin. Lab. 6:46.
23. Hortin, G. L.,, and A. B. Carter. 2002. Intraoperative parathyroid hormone testing: survey of testing program characteristics. Arch. Pathol. Lab. Med. 126:10451049. [PubMed][CrossRef]
24. Hsiao, A. L.,, K. A. Santucci,, J. Dziura,, and M. D. Baker. 2007. A randomized trial to assess the efficacy of point-of-care testing in decreasing length of stay in a pediatric emergency department. Pediatr. Emerg. Care 23:457462. [PubMed][CrossRef]
25. Hsieh, Y. H.,, J. J. Jung,, J. B. Shahan,, H. A. Pollack,, H. S. Hairston,, D. Moring-Parris,, G. D. Kelen,, and R. E. Rothman. 2011. Outcomes and cost analysis of 3 operational models for rapid HIV testing services in an academic inner-city emergency department. Ann. Emerg. Med. 58:S133S139. [PubMed][CrossRef]
26. Hughes, M. 2002. Market trends in point-of-care testing. Point of Care 1:8494.
27. Hurst, J.,, K. Nickel,, and L. H. Hilborne. 1998. Are physicians’ office laboratory results of comparable quality to those produced in other laboratory settings? JAMA 279:468471. [PubMed]
28.International Federation of Clinical Chemistry and Laboratory Medicine. 2001. IFCC reference measurement procedure for substance concentration determination of total carbon dioxide in blood, plasma or serum. Clin. Chem. Lab. Med. 39:283288. [PubMed][CrossRef]
29. Irvin, G. L.,, 3rd, and G. T. Deriso, 3rd. 1994. A new, practical intraoperative parathyroid hormone assay. Am. J. Surg. 168:466468. [PubMed]
30. Jani, I. V.,, N. E. Sitoe,, E. R. Alfai,, P. L. Chongo,, J. I. Quevedo,, B. M. Rocha,, J. D. Lehe,, and T. F. Peter. 2011. Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet 378:15721579. [PubMed][CrossRef]
31. Johnson, L. R.,, G. Doherty,, T. Lairmore,, J. F. Moley,, L. M. Brunt,, J. Koenig,, and M. G. Scott. 2001. Evaluation of the performance and clinical impact of a rapid intraoperative parathyroid hormone assay in conjunction with preoperative imaging and concise parathyroidectomy. Clin. Chem. 47:919925. [PubMed]
32. Jones, B. A.,, P. Bachner,, and P. J. Howanitz. 1993. Bedside glucose monitoring. A College of American Pathologists Q-Probes study of the program characteristics and performance in 605 institutions. Arch. Pathol. Lab. Med. 117:10801087. [PubMed]
33. Jones, B. A.,, and P. J. Howanitz. 1996. Bedside glucose monitoring quality control practices. A College of American Pathologists Q-Probes study of program quality control documentation, program characteristics, and accuracy performance in 544 institutions. Arch. Pathol. Lab. Med. 120:339345. [PubMed]
34. Jungheim, K.,, and T. Koschinsky. 2001. Risky delay of hypoglycemia detection by glucose monitoring at the arm. Diabetes Care 24:13031306. [PubMed]
35. Kabra, S.,, and R. Kanungo. 2012. Monitoring quality of HIV testing at point of care facilities in India. Indian J. Med. Microbiol. 30:129130. [PubMed][CrossRef]
36. Kagulire, S. C.,, P. Opendi,, P. D. Stamper,, J. L. Nakavuma,, L. A. Mills,, F. Makumbi,, R. H. Gray,, J. P. Shott,, D. Serwadda,, and S. J. Reynolds. 2011. Field evaluation of five rapid diagnostic tests for screening of HIV-1 infections in rural Rakai, Uganda. Int. J. STD AIDS 22:308309. [PubMed][CrossRef]
37. Keffer, J. H. 1995. Economic considerations of point-of-care testing. Am. J. Clin. Pathol. 104:S107S110. [PubMed]
38. Kilgore, M. L.,, S. J. Steindel,, and J. A. Smith. 1999. Continuous quality improvement for point-of-care testing using background monitoring of duplicate specimens. Arch. Pathol. Lab. Med. 123:824828. [PubMed][CrossRef]
39. Kilgore, M. L.,, S. J. Steindel,, and J. A. Smith. 1999. Cost analysis for decision support: the case of comparing centralized versus distributed methods for blood gas testing. J. Healthcare Manag. 44:207215. [PubMed]
40. Klarkowski, D. B.,, J. M. Wazome,, K. M. Lokuge,, L. Shanks,, C. F. Mills,, and D. P. O'Brien. 2009. The evaluation of a rapid in situ HIV confirmation test in a programme with a high failure rate of the WHO HIV two-test diagnostic algorithm. PLoS One 4:e4351. [PubMed][CrossRef]
41. Kost, G. J. 2001. Preventing medical errors in point-of-care testing: security, validation, safeguards, and connectivity. Arch. Pathol. Lab. Med. 125:13071315. [PubMed][CrossRef]
42. Kost, G. J. 2002. Principles and Practice of Point-of-Care Testing. Lippincott, Philadelphia, PA.
43. Kost, G. J.,, T. H. Nguyen,, and Z. Tang. 2000. Whole-blood glucose and lactate. Trilayer biosensors, drug interference, metabolism, and practice guidelines. Arch. Pathol. Lab. Med. 124:11281134. [PubMed][CrossRef]
44. Kuwa, K.,, T. Nakayama,, T. Hoshino,, and M. Tominaga. 2001. Relationships of glucose concentrations in capillary whole blood, venous whole blood and venous plasma. Clin. Chim. Acta 307:187192. [PubMed]
45. Laposata, M. 2001. Point-of-care coagulation testing: stepping gently forward. Clin. Chem. 47:801802. [PubMed]
46. Lee-Lewandrowski, E.,, M. Laposata,, K. Eschenbach,, C. Camooso,, D. M. Nathan,, J. E. Godine,, K. Hurxthal,, J. Goff,, and K. Lewandrowski. 1994. Utilization and cost analysis of bedside capillary glucose testing in a large teaching hospital: implications for managing point of care testing. Am. J. Med. 97:222230. [PubMed]
47. Lehman, C. M.,, R. C. Blaylock,, D. P. Alexander,, and G. M. Rodgers. 2001. Discontinuation of the bleeding time test without detectable adverse clinical impact. Clin. Chem. 47:12041211. [PubMed]
48. Losina, E.,, I. V. Bassett,, J. Giddy,, S. Chetty,, S. Regan,, R. P. Walensky,, D. Ross,, C. A. Scott,, L. M. Uhler,, J. N. Katz,, H. Holst,, and K. A. Freedberg. 2010. The “ART” of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS One 5:e9538. [PubMed][CrossRef]
49. Loten, C.,, J. Attia,, C. Hullick,, J. Marley,, and P. McElduff. 2010. Point of care troponin decreases time in the emergency department for patients with possible acute coronary syndrome: a randomised controlled trial. Emerg. Med. J. 27:194198. [PubMed][CrossRef]
50. McGarraugh, G.,, D. Price,, S. Schwartz,, and R. Weinstein. 2001. Physiological influences on off-finger glucose testing. Diabetes Technol. Ther. 3:367376. [PubMed]
51. Meek, R.,, G. Braitberg,, C. Nicolas,, and G. Kwok. 2012. Effect on emergency department efficiency of an accelerated diagnostic pathway for the evaluation of chest pain. Emerg. Med. Australas. 24:285293. [PubMed][CrossRef]
52.(Reference deleted.)
53. Nichols, J. H. 2007. Evidence-Based Practice for Point-of-Care Testing. NACB Guideline, Washington, DC.
54. Nichols, J. H. 2003. Quality in point-of-care testing. Expert Rev. Mol. Diagn. 3:563572. [PubMed][CrossRef]
55. Parvin, C. A.,, S. F. Lo,, S. M. Deuser,, L. G. Weaver,, L. M. Lewis,, and M. G. Scott. 1996. Impact of point-of-care testing on patients’ length of stay in a large emergency department. Clin. Chem. 42:711717. [PubMed]
56. Paxton, A. 2001. Survey says: labs shy on leukoreduction QC. CAP Today 15:62. [PubMed]
57. Plerhoples, W.,, F. L. Zwemer, Jr.,, and J. Bazarian. 2004. Point of care pregnancy testing provides staff satisfaction but does not change ED length of stay. Am. J. Emerg. Med. 22:460464. [PubMed]
58. Price, C. P. 2001. Point of care testing. Br. Med. J. 322:12851288. [PubMed]
59. Price, C. P.,, and J. M. Hicks. 1999. Point-of-Care Testing. AACC Press, Washington, DC.
59a. Price, C. P.,, A. St John,, and L. J. Kricka. 2010. Point-of-Care Testing: Needs, Opportunity, and Innovation, 3rd ed. AACC Press, Washington, DC.
60. Rosen, S.,, and M. P. Fox. 2011. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 8:e1001056. [PubMed][CrossRef]
61. Rossi, A. F.,, and D. Khan. 2004. Point of care testing: improving pediatric outcomes. Clin. Biochem. 37:456461. [PubMed][CrossRef]
62. Salem, J. K.,, R. R. Jones,, D. B. Sweet,, S. Hasan,, H. Torregosa-Arcay,, and L. Clough. 2011. Improving care in a resident practice for patients with diabetes. J. Grad. Med. Educ. 3:196202. [PubMed][CrossRef]
63. Schaden, E.,, O. Kimberger,, P. Kraincuk,, D. M. Baron,, P. G. Metnitz,, and S. Kozek-Langenecker. 2012. Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements. Br. J. Anaesth. 109:376381. [PubMed][CrossRef]
64. Shott, J. P.,, R. M. Galiwango,, and S. J. Reynolds. 2012. A quality management approach to implementing point-of-care technologies for HIV diagnosis and monitoring in sub-Saharan Africa. J. Trop. Med. article ID 651927, doi: 10.1155/2012/651927.
65. Singer, A. J.,, J. Ardise,, J. Gulla,, and J. Cangro. 2005. Point-of-care testing reduces length of stay in emergency department chest pain patients. Ann. Emerg. Med. 45:587591. [PubMed][CrossRef]
66. Sokoll, L. J.,, H. Drew,, and R. Udelsman. 2000. Intraoperative parathyroid hormone analysis: a study of 200 consecutive cases. Clin. Chem. 46:16621668. [PubMed]
67. Steindel, S. J.,, S. Granade,, J. Lee,, G. Avery,, L. M. Clarke,, R. W. Jenny,, and K. M. LaBeau. 2002. Practice patterns of testing waived under the clinical laboratory improvement amendments. Arch. Pathol. Lab. Med. 126:14711479. [PubMed][CrossRef]
68. Steindel, S. J.,, and P. J. Howanitz. 2001. Physician satisfaction and emergency department laboratory test turnaround time. Arch. Pathol. Lab. Med. 125:863871. [PubMed][CrossRef]
69. Stott, R. A.,, G. L. Hortin,, T. R. Wilhite,, S. B. Miller,, C. H. Smith,, and M. Landt. 1995. Analytical artifacts in hematocrit measurements by whole-blood chemistry analyzers. Clin. Chem. 41:306311. [PubMed]
70. Tamada, J. A.,, S. Garg,, L. Jovanovic,, K. R. Pitzer,, S. Fermi,, and R. O. Potts. 1999. Noninvasive glucose monitoring: comprehensive clinical results. Cygnus Research Team. JAMA 282:18391844. [PubMed]
71. Walensky, R. P.,, B. L. Morris,, W. M. Reichmann,, A. D. Paltiel,, C. Arbelaez,, L. Donnell-Fink,, J. N. Katz,, and E. Losina. 2011. Resource utilization and cost-effectiveness of counselor- vs. provider-based rapid point-of-care HIV screening in the emergency department. PLoS One 6:e25575. [PubMed][CrossRef]
72. Weber, C. F.,, K. Gorlinger,, D. Meininger,, E. Herrmann,, T. Bingold,, A. Moritz,, L. H. Cohn,, and K. Zacharowski. 2012. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 117:531547. [PubMed][CrossRef]
73. Weber, C. F.,, and K. Zacharowski. 2012. Perioperative point of care coagulation testing. Dtsch. Arztebl. Int. 109:369375. [PubMed][CrossRef]
74. Weitgasser, R.,, B. Gappmayer,, and M. Pichler. 1999. Newer portable glucose meters: analytical improvement compared with previous generation devices? Clin. Chem. 45:18211825. [PubMed]
75. Whitley, R. J.,, P. J. Santrach,, and D. L. Phillips. 2001. Establishing a quality management system for unit-use testing based on NCCLS proposed guideline (EP18-P). Clin. Chim. Acta 307:145149. [PubMed]
76. Wians, F. H.,, J. A. Balko,, R. M. Hsu,, W. Byrd,, and W. H. Snyder. 2000. Intraoperative vs. central laboratory PTH testing during parathyroid surgery. Lab. Med. 31:616621.
77. Wilson, D. P.,, C. K. Fairley,, D. Sankar,, H. Williams,, P. Keen,, T. R. Read,, and M. Y. Chen. 2011. Replacement of conventional HIV testing with rapid testing: mathematical modelling to predict the impact on further HIV transmission between men. Sex. Transm. Infect. 87:588593. [PubMed][CrossRef]
78. Winkelman, J. W.,, and M. J. Tanasijevic. 2002. Noninvasive testing in the clinical laboratory. Clin. Lab. Med. 22:547558. [PubMed]
79. Winkelman, J. W.,, D. R. Wybenga,, and M. J. Tanasijevic. 1994. The fiscal consequences of central vs distributed testing of glucose. Clin. Chem. 40:16281630. [PubMed]


Generic image for table
Table 25.1

Management challenges of POCT

Citation: Hortin G, Doern C. 2014. Management of Point-of-Care Testing, p 471-487. In Garcia L (ed), Clinical Laboratory Management, Second Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817282.ch25
Generic image for table
Table 25.2

Goals of management of POCT

Citation: Hortin G, Doern C. 2014. Management of Point-of-Care Testing, p 471-487. In Garcia L (ed), Clinical Laboratory Management, Second Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817282.ch25
Generic image for table
Table 25.3

Common advantages and disadvantages of POCT versus central laboratory testing

Citation: Hortin G, Doern C. 2014. Management of Point-of-Care Testing, p 471-487. In Garcia L (ed), Clinical Laboratory Management, Second Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817282.ch25

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error